BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36740808)

  • 21. Panel gene profiling of small bowel adenocarcinoma: Results from the NADEGE prospective cohort.
    Aparicio T; Svrcek M; Henriques J; Afchain P; Lièvre A; Tougeron D; Gagniere J; Terrebonne E; Piessen G; Legoux JL; Lecaille C; Pocard M; Gornet JM; Zaanan A; Lavau-Denes S; Lecomte T; Deutsch D; Vernerey D; Puig PL
    Int J Cancer; 2021 Apr; 148(7):1731-1742. PubMed ID: 33186471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Alterations of DPC4/SMAD4/MADH4 gene detected in paraffin-embedded tissues of human pancreatic carcinomas].
    Gu LJ; Chen J; Liu TH; Cui QC; Lu ZH; Li L; Gao J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr; 24(2):165-9. PubMed ID: 12905795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreatic adenocarcinomas without KRAS, TP53, CDKN2A and SMAD4 mutations and CDKN2A/CDKN2B copy number alterations: a review of the genomic landscape to unveil therapeutic avenues.
    Voutsadakis IA; Digklia A
    Chin Clin Oncol; 2023 Feb; 12(1):2. PubMed ID: 36922358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological characterization of SMAD4-mutated intestinal adenocarcinomas: A case-control study.
    Liao X; Hao Y; Zhang X; Ward S; Houldsworth J; Polydorides AD; Harpaz N
    PLoS One; 2019; 14(2):e0212142. PubMed ID: 30730996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of SMAD4 function in small intestinal adenocarcinomas: comparison of genetic and immunohistochemical findings.
    Bläker H; Aulmann S; Helmchen B; Otto HF; Rieker RJ; Penzel R
    Pathol Res Pract; 2004; 200(1):1-7. PubMed ID: 15157044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer.
    Blackford A; Serrano OK; Wolfgang CL; Parmigiani G; Jones S; Zhang X; Parsons DW; Lin JC; Leary RJ; Eshleman JR; Goggins M; Jaffee EM; Iacobuzio-Donahue CA; Maitra A; Cameron JL; Olino K; Schulick R; Winter J; Herman JM; Laheru D; Klein AP; Vogelstein B; Kinzler KW; Velculescu VE; Hruban RH
    Clin Cancer Res; 2009 Jul; 15(14):4674-9. PubMed ID: 19584151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic and epigenetic alterations of familial pancreatic cancers.
    Brune K; Hong SM; Li A; Yachida S; Abe T; Griffith M; Yang D; Omura N; Eshleman J; Canto M; Schulick R; Klein AP; Hruban RH; Iacobuzio-Donohue C; Goggins M
    Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3536-42. PubMed ID: 19064568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequent loss of heterozygosity of SMAD4 locus and prognostic impacts of SMAD4 immunohistochemistry in gastric adenocarcinoma with enteroblastic differentiation.
    Yatagai N; Saito T; Akazawa Y; Hayashi T; Yanai Y; Tsuyama S; Murakami T; Ueyama H; Watanabe S; Nagahara A; Yao T
    Hum Pathol; 2019 Jun; 88():18-26. PubMed ID: 30946932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comprehensive examination of Smad4, Smad6 and Smad7 mRNA expression in pancreatic ductal adenocarcinoma.
    Singh P; Wig JD; Srinivasan R; Radotra BD
    Indian J Cancer; 2011; 48(2):170-4. PubMed ID: 21768661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphatase PPM1A is a novel prognostic marker in pancreatic ductal adenocarcinoma.
    Fan J; Yang MX; Ouyang Q; Fu D; Xu Z; Liu X; Mino-Kenudson M; Geng J; Tang F
    Hum Pathol; 2016 Sep; 55():151-8. PubMed ID: 27195906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of KRAS and SMAD4 mutations in formalin-fixed paraffin-embedded tissues as a biomarker for pancreatic cancer.
    Yokose T; Kitago M; Matsuda S; Sasaki Y; Masugi Y; Nakamura Y; Shinoda M; Yagi H; Abe Y; Oshima G; Hori S; Yusuke F; Nakano Y; Endo Y; Abe K; Tokino T; Kitagawa Y
    Cancer Sci; 2020 Jun; 111(6):2174-2182. PubMed ID: 32314446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inactivation of Smad4 in gastric carcinomas.
    Powell SM; Harper JC; Hamilton SR; Robinson CR; Cummings OW
    Cancer Res; 1997 Oct; 57(19):4221-4. PubMed ID: 9331080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced Smad4 expression and DNA topoisomerase inhibitor chemosensitivity in non-small cell lung cancer.
    Ziemke M; Patil T; Nolan K; Tippimanchai D; Malkoski SP
    Lung Cancer; 2017 Jul; 109():28-35. PubMed ID: 28577946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis.
    Moore PS; Orlandini S; Zamboni G; Capelli P; Rigaud G; Falconi M; Bassi C; Lemoine NR; Scarpa A
    Br J Cancer; 2001 Jan; 84(2):253-62. PubMed ID: 11161385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ki-ras and p53 mutations in pancreatic ductal adenocarcinoma.
    Rall CJ; Yan YX; Graeme-Cook F; Beauchamp R; Yandell DW; Povoski SP; Rustgi AK
    Pancreas; 1996 Jan; 12(1):10-7. PubMed ID: 8927612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No SMAD4 hypermethylation in colorectal cancer.
    Roth S; Laiho P; Salovaara R; Launonen V; Aaltonen LA
    Br J Cancer; 2000 Oct; 83(8):1015-9. PubMed ID: 10993648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A clinically relevant model of human pancreatic adenocarcinoma identifies patterns of metastasis associated with alterations of the TGF-beta/Smad4 signaling pathway.
    Holloway S; Davis M; Jaber R; Fleming J
    Int J Gastrointest Cancer; 2003; 33(1):61-9. PubMed ID: 12909738
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Wang F; Xia X; Yang C; Shen J; Mai J; Kim HC; Kirui D; Kang Y; Fleming JB; Koay EJ; Mitra S; Ferrari M; Shen H
    Clin Cancer Res; 2018 Jul; 24(13):3176-3185. PubMed ID: 29602802
    [No Abstract]   [Full Text] [Related]  

  • 39. Analysis of K-ras gene mutations in rare pancreatic and ampullary tumours.
    Ebert MP; Hoffmann J; Schneider-Stock R; Kasper HU; Schulz HU; Lippert H; Roessner A; Malfertheiner P
    Eur J Gastroenterol Hepatol; 1998 Dec; 10(12):1025-9. PubMed ID: 9895049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The expression of S100A8 in pancreatic cancer-associated monocytes is associated with the Smad4 status of pancreatic cancer cells.
    Sheikh AA; Vimalachandran D; Thompson CC; Jenkins RE; Nedjadi T; Shekouh A; Campbell F; Dodson A; Prime W; Crnogorac-Jurcevic T; Lemoine NR; Costello E
    Proteomics; 2007 Jun; 7(11):1929-40. PubMed ID: 17469085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.